# US 2025/0375123 A1 · Analysis of gas samples for determination of physiological states and disease states

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375123 A1
- Document ID: US20250375123A1
- Status: Published application
- Kind: A1
- Application number: 19/180,552
- Filed: 2025-04-16
- Published: 2025-12-11
- Earliest claimed: 2020-02-12
- Applicants: New York University
- Inventors: Kalle Levon; Hao-Chun Chiang; Nikita Grigoryev; Freya Schnabel; Ivan Selesnick
- Web page: https://patentgrep.com/patent/US20250375123A1

## CPC

- A61B 5/082: {Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath (A61B5/083, A61B5/091 take precedence)}
- A61B 5/097: Devices for facilitating collection of breath or for directing breath into or through measuring devices
- G01N 33/0075: {for multiple spatially distributed sensors, e.g. for environmental monitoring}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided methods of detecting physiological states and/or disease states of an individual. Also provided are systems for detecting physiological states and/or disease states of an individual. The method are based on the response of organic semiconducting materials to one or more components of a biogas sample from an individual.

## Claims

### Claim 1

A method for identifying the presence or absence of a physiological state and/or a disease state by analysis of a test biogas sample from an individual or a biological sample comprising:
providing an array of sensors wherein each sensor of the array comprises an organic semiconducting material, wherein at least two sensors of the array have different organic semiconducting material or have the same semiconducting material at different concentrations, and the oxidation state of the organic semiconducting material of each sensor changes in response to one or more specific volatile compounds, and the at least two sensors can detect distinct volatile compounds or the same volatile compound at different concentrations; and
contacting the array of sensors with the test biogas sample, wherein if the one or more specific volatile compounds are present, the distinct sensors reactive to the specific volatile compounds or a different concentration of the same compound exhibit separately detectable responses and based on the combination of detected responses, the presence or absence of the physiological state and/or disease state is identified.

### Claim 2 (depends on 1)

The method of claim 1, wherein the organic semiconducting material is independently for each sensor chosen from organic semiconducting oligomers, organic semiconducting polymers, and combinations thereof, and, optionally, when the organic semiconducting material is an organic semiconducting polymer, the organic semiconducting polymer is modified post polymerization.

### Claim 3 (depends on 2)

The method of claim 2, wherein the organic semiconducting material is independently for each sensor chosen from polyaniline (PANI), polythiophene, polypyrrole, substituted analogs thereof, block copolymers comprising one or more block thereof, graft copolymers comprising one or more block thereof, network polymers thereof, and combinations thereof.

### Claim 4 (depends on 2)

The method of claim 2, wherein the organic semiconducting oligomers have a molecular weight (Mw and/or Mn) of 10-500 g/mol, and/or the organic semiconducting polymers have a molecular weight (Mw and/or Mn) of 200-500,000 g/mol.

### Claim 5 (depends on 1)

The method of claim 1, wherein the individual organic semiconducting material(s) is/are amorphous or at least partially crystalline or amorphous.

### Claim 6 (depends on 1)

The method of claim 1, wherein the organic semiconducting material(s) further comprise a dopant and the dopant is independently for each sensor chosen from oxidants, acids, polymers, and combinations thereof, or
the organic semiconducting material is a self-doped organic conducting material, copolymers thereof, or network polymers thereof.

### Claim 7 (depends on 6)

The method of claim 6, wherein the dopant concentration is independently for each sensor 2 to 50 weight % (based on the total weight of the organic semiconducting material and dopant(s)).

### Claim 8 (depends on 1)

The method of claim 1, wherein the array of sensors is a plurality of sensors and the plurality of sensors is provided as a stack.

### Claim 9 (depends on 8)

The method of claim 8, wherein the array of sensors comprises one or more stacked sensors.

### Claim 10 (depends on 1)

The method of claim 1, wherein the array of sensors are arranged as a planar array and/or vertically stacked array.

### Claim 11 (depends on 1)

The method of claim 1, wherein the number of distinct sensors in the array of sensor is chosen from 2 to 1,000.

### Claim 12 (depends on 1)

The method of claim 1, wherein one or more of the distinct sensors further comprise one or more polymeric materials other than the organic semiconducting material(s).

### Claim 13 (depends on 1)

The method of claim 1, wherein the test biogas sample is breath and/or a gas sample derived from one or more bodily fluid(s), cells, stool, tissue, or a combination thereof.

### Claim 14 (depends on 1)

The method of claim 1, further comprising recording the response from the sensor array and generating a pattern based on the response of the plurality of distinct sensors; and comparing the pattern obtained from the test biogas sample to a pattern obtained from a reference biogas sample, which corresponds to a particular physiological or disease state to determine the presence or absence of the physiological state and/or disease state.

### Claim 15 (depends on 14)

The method of claim 14, wherein the comparing comprises subjecting the response of the plurality of distinct sensors to a predetermined rule set, wherein the predetermined rule set defines the physiological state(s) and/or disease state(s), thereby identifying the presence or absence of particular physiological state(s) and/or disease state(s), and the comparing optionally comprises utilizing principal component analysis, vector analysis, fuzzy logic, Monte Carlo analysis, or a combination thereof.

### Claim 16 (depends on 1)

The method of claim 1, wherein the response is a spectrophotometric response or electronic response.

### Claim 17 (depends on 1)

The method of claim 1, wherein the disease state is chosen from cancers, diabetes, autoimmune diseases, mental illnesses, metabolic diseases, and combinations thereof and/or the physiological state is a natural physiological state or an altered physiological state.

### Claim 18

A system comprising:
a vessel for volatilizing a liquid, the vessel having a vapor outlet;
a channel in communication with the vapor outlet for receiving evaporate from the vessel;
an array of sensors having at least one sensor, arranged as a planar array and/or vertically stacked array, wherein the at least one sensor is configured to contact evaporate in the channel, and wherein each sensor of the at least one sensor comprises:
a first electrical contact;
a second electrical contact; and
the sensors of the array of sensors comprise an organic semiconducting material, wherein at least two sensors have different organic semiconducting material or have the same semiconducting material at different concentrations, and the oxidation state of the organic semiconducting material of each sensor changes in response to one or more specific volatile compounds, and at least two sensors of the array of sensors can detect distinct volatile compounds or the same volatile compound at different concentrations.
